Qure.ai

Qure.ai is a leading healthcare AI company that develops deep learning solutions to make diagnostic imaging accurate, accessible, and affordable. Founded in 2016, Qure.ai has become one of the world's most adopted healthcare AI platforms, with a mission to use artificial intelligence to make healthcare more accessible and equitable for patients worldwide. The company's AI-powered solutions cover a range of medical imaging applications, including chest X-rays, head CT scans, and quantification tools for CT and MRI scans. Qure.ai's flagship product, qXR, is an AI-powered chest X-ray interpretation tool that can detect multiple abnormalities, including signs of tuberculosis and lung cancer. Their qER solution provides rapid triage for head CT scans, assisting in the detection of critical abnormalities such as intracranial hemorrhages. Qure.ai has demonstrated significant clinical impacts, including expediting the diagnosis and treatment of conditions like stroke and tuberculosis. The company has partnered with major healthcare organizations and initiatives, such as AstraZeneca's EDISON Alliance's 1 Billion Lives Challenge, which aims to screen 5 million patients by 2025. Qure.ai's technology is designed to integrate with existing medical equipment, making it adaptable to various healthcare settings, including resource-constrained areas. The company has received multiple FDA clearances for its AI solutions, validating their clinical efficacy. Qure.ai is actively working on expanding its solutions to pediatric care and is continuously innovating to address global healthcare challenges. With a focus on improving patient outcomes and supporting healthcare professionals, Qure.ai is at the forefront of using AI to transform diagnostic healthcare worldwide.